Stockscreener 앱 받기
53.68
1.05%
0.56
시간 외 거래:
53.68
Exact Sciences Corp 주식(EXAS)의 최신 뉴스
Exact Sciences (EXAS) Stock Trades Up, Here Is Why - Yahoo Finance
JAMA Oncology Publication Strengthens Evidence for Oncotype DX® Test Reliability Across Racial and Ethnic Groups - ADVFN
Exact Sciences (EXAS): Exploring Current Valuation After Recent Share Price Swings - Yahoo Finance
Pallas Capital Advisors LLC Boosts Holdings in Exact Sciences Corporation $EXAS - MarketBeat
273,936 Shares in Exact Sciences Corporation $EXAS Purchased by Kingstone Capital Partners Texas LLC - MarketBeat
Matthew Lillard Knows There's Nothing Scary About Screening for Colon Cancer: (Exclusive) - People.com
Exact Sciences : Latest Corporate Presentation - MarketScreener
Why Exact Sciences (EXAS) is a Top Momentum Stock for the Long-Term - Yahoo Finance
2025-09-22 | Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test | NDAQ:EXAS | Press Release - Stockhouse
Horror Icon Matthew Lillard and Exact Sciences Help Adults 45+ Conquer Fear and Get Screened for Colon Cancer with the Cologuard® Test - The Joplin Globe
Exact Sciences, Healthmine Partner to Boost Cologuard Screening Rates via Health Plan Incentives - Insider Monkey
Exact Sciences Corporation (NASDAQ:EXAS) Short Interest Update - MarketBeat
Zevenbergen Capital Investments LLC Sells 149,781 Shares of Exact Sciences Corporation $EXAS - MarketBeat
Brokerages Set Exact Sciences Corporation (NASDAQ:EXAS) Target Price at $68.05 - MarketBeat
Can Exact Sciences Corporation generate free cash flow2025 Analyst Calls & Fast Gaining Stock Strategy Reports - خودرو بانک
UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC Acquires 1,707,287 Shares of Exact Sciences Corporation $EXAS - MarketBeat
EXACT Sciences Corp. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Healthmine and Exact Sciences Partner to Combine At-Home CRC Screening with Health Plan Incentives to Boost Preventive Care - Yahoo Finance
Q3 EPS Estimates for Exact Sciences Boosted by William Blair - MarketBeat
DLD Asset Management LP Invests $3.40 Million in Exact Sciences Corporation $EXAS - MarketBeat
Nasdaq Moves: Should I set a stop loss on QRHCJuly 2025 PostEarnings & Low Risk High Reward Ideas - خودرو بانک
Woodline Partners LP Increases Stock Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Aug Sectors: Is Exact Sciences Corporation showing insider buyingChart Signals & Weekly Chart Analysis and Trade Guides - خودرو بانک
Belpointe Asset Management LLC Has $2.26 Million Stake in Exact Sciences Corporation $EXAS - MarketBeat
FY2025 EPS Estimates for Exact Sciences Lifted by Analyst - MarketBeat
Exact Sciences CEO on Launch of Multi-Cancer Blood Test - MarketScreener
Why Exact Sciences (EXAS) is a Top Growth Stock for the Long-Term - Yahoo Finance
Energy Moves: Is CARGO Therapeutics Inc. forming bullish engulfing patternsIPO Watch & Weekly Sector Rotation Insights - خودرو بانک
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Sahm
Scientech Research LLC Makes New $915,000 Investment in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences (NASDAQ:EXAS) Given New $85.00 Price Target at Craig Hallum - MarketBeat
Curi RMB Capital LLC Sells 10,902 Shares of Exact Sciences Corporation $EXAS - MarketBeat
FMR LLC Reduces Stake in Exact Sciences Corp by 30.88% - GuruFocus
Graham Capital Management L.P. Buys New Holdings in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences Launches Cancerguard MCED Blood Test, Stock Climbs - Nasdaq
Exact Sciences price target raised to $85 from $65 at Craig-Hallum - Yahoo Finance
Vident Advisory LLC Sells 7,937 Shares of Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences (NASDAQ:EXAS) Cut to Hold at Zacks Research - MarketBeat
Exact Sciences (EXAS) Is Up 11.2% After Launching Cancerguard Multi-Cancer Blood Test With Quest Diagnostics - simplywall.st
Exact Sciences launches blood test that can detect cancers earlier - Wisconsin State Journal
EFG Asset Management North America Corp. Decreases Stock Position in Exact Sciences Corporation $EXAS - MarketBeat
Exact Sciences launches Cancerguard blood test for early cancer detection By Investing.com - Investing.com Australia
Exact Sciences Corporation $EXAS Stock Position Decreased by Northwestern Mutual Wealth Management Co. - MarketBeat
Exact Sciences Launches Cancerguard™, Multi-Cancer Early Detection Blood Test - Nasdaq
Exact Sciences’ Cancerguard MCED test launches for $689 - BioWorld MedTech
Should You Continue to Hold EXAS Stock in Your Portfolio? - Nasdaq
Exact Sciences launches Cancerguard blood test for early cancer detection - Investing.com
Exact Sciences launches Cancerguard multi-cancer blood test at $689 - StreetInsider
Exact Sciences Launches Cancerguard™, First-of-Its-Kind Multi-Cancer Early Detection Blood Test - Quantisnow
1.66%
자본화:
|
볼륨(24시간):